Bicara Therapeutics INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
RA Capital Management and its affiliates increased their beneficial ownership in Bicara Therapeutics Inc. to 11.5% following a $40 million investment in a public offering.